Sangamo BioSciences | SGMO - Lucro Bruto Sobre Vendas





Lucro Bruto Sobre Vendas Alterar Data
Alaunos Therapeutics USD -1.13M 1.11M 2024-09
Alnylam Pharmaceuticals USD 992.69M 167.68M 2026-06
Amgen USD 5.87B 1.02B 2026-03
Bayer EUR 6.33B 1.84B 2026-06
BioCryst Pharmaceuticals USD 214.41M 61.36M 2026-06
Biogen USD 2.12B 307M 2026-06
BioMarin Pharmaceutical USD 713.42M 142.21M 2026-06
Cipla INR 44.1B 5B 2026-06
Clal Biotechnology ILS -857K 1.42M 2022-06
Compugen USD 352K 63.44M 2026-03
CSL USD 4.46B 2.71B 2025-12
Gilead Sciences USD 6.8B 1.29B 2026-06
GlaxoSmithKline GBP 6.51B 757M 2026-06
Grifols EUR 766.49M 39.74M 2024-12
Ionis Pharmaceuticals USD 265M 22M 2026-06
J&J USD 18.55B 1.31B 2026-06
Karyopharm Therapeutics USD 33.72M 1.13M 2026-03
Merck USD 12.09B 1.24B 2026-03
Novartis USD 11.24B 1.18B 2026-06
Omeros USD -33.16M 18.52M 2024-06
Pfizer USD -248M 11.29B 2026-06
Roche Holding CHF 22.69B 600M 2026-06
Sangamo BioSciences -2.39M 1.09M 2024-06
Sanofi EUR 8.71B 602M 2026-06
Sarepta Therapeutics USD 251.15M 370.2M 2026-06
Tectonic Therapeutic USD 0 0 2025-03
Ultragenyx Pharmaceutical USD 180M 74M 2026-06
Vertex Pharmaceuticals USD 2.84B 242.4M 2026-06